Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Topiramate 250mg/5ml oral suspension
040801050AABZBZ
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 25mg/5ml oral solution
040801050AACECE
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 30mg/5ml oral liquid
040801050AABLBL
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 35mg/5ml oral liquid
040801050AABRBR
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 5mg/5ml oral liquid
040801050AABIBI
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 6.25mg/5ml oral liquid
040801050AABHBH
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 62.5mg/5ml oral suspension
040801050AACDCD
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 67.5mg/5ml oral liquid
040801050AABUBU
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 75mg/5ml oral liquid
040801050AAASAS
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topiramate 8mg/5ml oral suspension
040801050AACFCF
|
Topiramate | Topiramate | Central Nervous System | No data available |
|
Topogyne 400microgram tablets
0701010X0BBAAAA
|
Topogyne | Misoprostol (Gynaecology) | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Topotecan 1mg capsules
0801050AFAAADAD
|
Topotecan | Topotecan | Malignant Disease and Immunosuppression | No data available |
|
Topotecan 1mg powder for solution for infusion vials
0801050AFAAAAAA
|
Topotecan | Topotecan | Malignant Disease and Immunosuppression | No data available |
|
Topotecan 1mg/1ml solution for infusion vials
0801050AFAAAFAF
|
Topotecan | Topotecan | Malignant Disease and Immunosuppression | No data available |
|
Topotecan 250microgram capsules
0801050AFAAACAC
|
Topotecan | Topotecan | Malignant Disease and Immunosuppression | No data available |
|
Topotecan 4mg powder for solution for infusion vials
0801050AFAAABAB
|
Topotecan | Topotecan | Malignant Disease and Immunosuppression | No data available |
|
Topotecan 4mg/4ml solution for infusion vials
0801050AFAAAEAE
|
Topotecan | Topotecan | Malignant Disease and Immunosuppression | No data available |
|
Toradol 10mg tablets
1501042E0BBACAC
|
Toradol | Ketorolac trometamol | Anaesthesia | No data available |
|
Toradol 10mg/1ml solution for injection ampoules
1501042E0BBABAB
|
Toradol | Ketorolac trometamol | Anaesthesia | No data available |
|
Torasemide 20mg tablets
0202020U0AAAFAF
|
Torasemide | Torasemide | Cardiovascular System | No data available |
|
Torbetol acne lotion
1311020L0CEAAA0
|
Torbetol (Topical) | Chlorhexidine gluconate | Skin | No data available |
|
Torisel 30mg/1.2ml concentrate for inf vials and diluent
0801050AUBBAAAA
|
Torisel | Temsirolimus | Malignant Disease and Immunosuppression | No data available |
|
Trabectedin 1mg powder for solution for infusion vials
0801050AVAAABAB
|
Trabectedin | Trabectedin | Malignant Disease and Immunosuppression | No data available |
|
Trabectedin 250microgram inf vials
0801050AVAAAAAA
|
Trabectedin | Trabectedin | Malignant Disease and Immunosuppression | No data available |
|
TracFlex Plus shower cap
20050200326
|
TracFlex Plus shower cap | Tracheostomy & Laryngectomy Appliances | Dressings | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.